News Daily News More Evidence of Lower Fracture Risk With DOACs Versus Warfarin Todd Neale May 19, 2020
News Daily News HRS 2020 ‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib Todd Neale May 14, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Conference News ACC 2020 PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery Yael L. Maxwell March 31, 2020
News Conference News ACC 2020 Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds Todd Neale March 25, 2020
News Conference News ISC 2020 Optimal Time to Start Anticoagulation After Stroke Remains Unclear Todd Neale February 27, 2020
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020
News Conference News AHA 2019 Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS Todd Neale November 20, 2019
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Conference News HRS 2019 Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib Todd Neale May 17, 2019
News Conference News EHRA 2019 Survey Says . . . Patients Like NOACs Better Than Warfarin Todd Neale March 17, 2019
News Daily News High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin Shelley Wood March 08, 2019
News Daily News DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight Todd Neale February 25, 2019
News Conference News ISC 2019 Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects Todd Neale February 13, 2019
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019